Biopharma Stock Updates - 12/07/2020

Presentations at 62nd American Society of Hematology Annual Meeting

#PGEN (-3.31%)

Precigen Presents New Data Supporting the Safety, Clinical Activity, Expansion and Persistence of #PRGN-3006 UltraCAR-T®
 

#SGMO (-6.66%)

Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels in 3x10¹³ VG/KG Cohort Through One Year Following Hemophilia A Gene Therapy
 

#TGTX (-2.10%)

TG Therapeutics Announces Pivotal Data from the #UNITY-CLL and #UNITY-NHL Clinical Trials Presented at the 62nd American Society of Hematology Annual Meeting

TG Therapeutics Announces Triple Combination Data Presentations at the at the 62nd American Society of Hematology Annual Meeting
 

Updates

#DRRX (+0.78%) - DURECT Corporation to Sell its #LACTEL® Absorbable Polymer Product Line to Evonik for $15 Million
 

#MNKD (-7.8%) - MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.
 

#RDHL (-1.81%) - RedHill Biopharma Extends #Talicia® Unrestricted National and Regional Commercial Coverage to Over 40 Million Additional Americans
 

#SCPH (-34.78%) - scPharmaceuticals Inc. Receives Complete Response Letter from FDA for #FUROSCIX®
 

#VBIV (+2.18%) - VBI Vaccines Selects Syneos Health as Commercialization Partner for Prophylactic 3-Antigen Hepatitis B Vaccine